Mechanism: Mitochondrial NAD+/NADH ratio dictates telomeric redox state, influencing G-quadruplex stability and shelterin binding to control p53-mediated senescence. Readout: Readout: Elevating NAD+ with Nicotinamide Riboside reduces telomere-associated DDR foci and SASP cytokines despite unchanged telomere length, lowering the senescence score.
Hypothesis
Telomere length does not merely count divisions; it reflects the mitochondrial NAD+/NADH redox state through a telomere‑associated redox capacitor that modulates shelterin complex stability and p53‑dependent senescence signaling.
Mechanistic Basis
Telomeric G‑quadruplex structures can bind and transfer electrons, acting as a redox‑sensitive capacitor. Changes in mitochondrial NAD+/NADH alter local ROS production, shifting the redox potential at telomeres. A more oxidized environment destabilizes G‑quadruplexes, reducing shelterin binding and exposing telomeric DNA to DDR kinases. This triggers p53 activation and repression of PGC-1α/β, suppressing mitochondrial biogenesis and amplifying ROS—a feedforward loop that couples telomere status to metabolic dysfunction independent of replication count.[https://pmc.ncbi.nlm.nih.gov/articles/PMC5492019/][https://pmc.ncbi.nlm.nih.gov/articles/PMC3741661/][https://pmc.ncbi.nlm.nih.gov/articles/PMC7411297/][https://pmc.ncbi.nlm.nih.gov/articles/PMC6451386/]
Testable Predictions
- Elevating the mitochondrial NAD+/NADH ratio (e.g., with nicotinamide riboside) will decrease telomere‑associated ROS signaling, lower TIF formation, and reduce p53‑mediated senescence markers without altering telomere length.
- Conversely, inducing mitochondrial NADH accumulation (via complex I inhibition) will increase telomere oxidation, increase shelterin dissociation, heighten DDR signaling, and accelerate senescence even when telomerase is active.
- Mutating G‑quadruplex‑forming sequences in telomeric repeats will uncouple telomere length from redox‑dependent senescence, making cells insensitive to NAD+/NADH manipulations.
Experimental Design
- Use human fibroblasts with telomerase knocked out to maintain constant short telomeres.
- Treat groups with: (a) vehicle, (b) NR to raise NAD+, (c) rotenone to lower NAD+/NADH, (d) NR + rotenone as control.
- Measure over 72 h: telomere length (Q‑FISH), mitochondrial NAD+/NADH (fluorescent biosensor), ROS (MitoSOX), telomere‑associated DDR foci (53BP1/TIF co‑localization), shelterin occupancy (ChIP‑TRF1/2), p53 phosphorylation, and SASP cytokines (IL‑6, IL‑8).
- Parallel experiment with CRISPR‑edited telomeric repeats lacking G‑quadruplex potential to test prediction 3.
Potential Outcomes and Implications
If NR reduces TIFs and senescence despite unchanged telomere length, it supports telomeres as redox sensors. If G‑quadruplex mutants blunt the NAD+/NADH effect, it confirms the proposed capacitor mechanism. A positive result would reframe telomere‑targeted interventions: modulating mitochondrial redox state could delay senescence without telomerase activation, offering a new avenue for age‑related disease mitigation and cancer prevention where telomere length remains stable.
Comments
Sign in to comment.